CIK 0001824293 · <br>Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824369909
- Phone
- (619) 400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-18 | Chaturvedi Vipin Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +43,222 | 43,222 | ||
| 2025-09-18 | Hertz Walter Marc Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +103,067 | 103,067 | ||
| 2025-09-18 | Baker David Charles Director | Grant or award · Stock Option (Right to Buy) | +23,605 | 23,605 | ||
| 2025-09-18 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +23,605 | 23,605 | ||
| 2025-09-18 | Rongen Roelof Director | Grant or award · Stock Option (Right to Buy) | +23,605 | 23,605 | ||
| 2025-09-18 | Szekeres David Leslie Director | Grant or award · Stock Option (Right to Buy) | +39,897 | 39,897 | ||
| 2025-09-18 | Kelly Leanne Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +43,222 | 43,222 | ||
| 2025-08-26 | Hertz Walter Marc Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +26,688 | 26,688 | ||
| 2025-08-26 | Szekeres David Leslie Director | Grant or award · Stock Option (Right to Buy) | +10,276 | 10,276 | ||
| 2025-08-26 | Baker David Charles Director | Grant or award · Stock Option (Right to Buy) | +5,994 | 5,994 | ||
| 2025-08-26 | Rongen Roelof Director | Grant or award · Stock Option (Right to Buy) | +5,994 | 5,994 | ||
| 2025-08-26 | Chaturvedi Vipin Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +11,854 | 11,854 | ||
| 2025-08-26 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +5,994 | 5,994 | ||
| 2025-08-26 | Kelly Leanne Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +11,854 | 11,854 | ||
| 2025-08-13 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +4,527 | 4,527 | ||
| 2025-08-13 | Baker David Charles Director | Grant or award · Stock Option (Right to Buy) | +4,527 | 4,527 | ||
| 2025-08-13 | Rongen Roelof Director | Grant or award · Stock Option (Right to Buy) | +4,527 | 4,527 | ||
| 2025-08-13 | Szekeres David Leslie Director | Grant or award · Stock Option (Right to Buy) | +7,545 | 7,545 | ||
| 2025-01-23 | Kelly Leanne Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +43,319 | $0.69 | $30K | 43,319 |
| 2025-01-23 | Chaturvedi Vipin Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +43,319 | $0.69 | $30K | 43,319 |
Page 1 of 3 · 60 trades